SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Momenta Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Ian@SI who wrote (2752)2/8/2011 4:37:10 PM
From: Biomaven  Read Replies (1) | Respond to of 3027
 
Is this the likely reason for TEVA being down over $3 ?

Nope - light on revenue and on guidance.

Peter



To: Ian@SI who wrote (2752)2/8/2011 4:57:47 PM
From: pollyvonwog  Respond to of 3027
 
Nope, Biomaven hit the nail on the head in regards to TEVA's decline.

T-enox: I'd be shocked if we ever hear a peep again from TEVA regardings its app



To: Ian@SI who wrote (2752)2/8/2011 6:04:10 PM
From: Jeffry K. Smith  Read Replies (1) | Respond to of 3027
 
I just knew I should have gotten back in MNTA!

Have they heard anything more on their application for a generic version of Copaxazone?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News